# Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy

> **NCT00911911** · NA · COMPLETED · sponsor: **Centre Oscar Lambret** · enrollment: 66 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Blood sampling
- **PROCEDURE:** BIOPSY
- **PROCEDURE:** SURGERY

## Key facts

- **NCT ID:** NCT00911911
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02-22
- **Primary completion:** 2009-01
- **Final completion:** 2012-01-16
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911911, "Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00911911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*